A team of UK researchers have homed in on a protein, called RIT1, that may act as a master switch in the brain. A new five-year, $2.5 million grant from the National Institutes of Health will help them explore RIT1 as a possible target for treatments to counteract brain injury.
The third annual International Society of Neurogastronomy Symposium brought together experts from the worlds of food and neuroscience to explore what we eat and why.
Dr. Craig Van Horne, neurosurgeon, and Dr. George Quintero, DBS neurophysiologist at UK HealthCare's Neuroscience Institute, discuss deep brain stimulation in Sunday's Herald-Leader Your Health column.
Case Western Reserve and UK's SCoBIRC were able to show the existence of a parallel neural network that could potentially restore diaphragm function after spinal cord injury. Perhaps more amazing is that this research is credited to a group of young scientists.
Led by a multidisciplinary team of clinicians and scientists, the studies aim to develop new treatments using existing therapies that protect brain tissue after a stroke, and to learn more about the physiology of the event.
Last summer, a group from the UK Brain Restoration center, led by Dr. Craig van Horne, capped off a series of conferences held at a number of renowned Chinese university hospitals by performing the first-ever deep brain stimulation surgery for a Parkinson’s disease patient at The First Affiliated Hospital of Zhengzhou University in Henan, China.
In a prime example of the unique type of cross-collaboration that takes place at academic medical centers, Markey's stem cell lab is working together with the Kentucky Neuroscience Institute to bring an innovative stroke clinical trial to UK HealthCare.
Many cancer survivors experience devastating cognitive impairment following chemotherapy. Researchers at UK are trying to identify strategies to relieve these symptoms.
A team of researchers, led by Professor Suzanne Segerstrom, extends its psychological and immunological health research to include brain health, supported by a $3.3 million grant from the National Institute on Aging.
Gentry's research on a plant protein that stores sugars like the human protein implicated in Lafora disease, led him to an international partnership to find a cure.
